Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia

« Previous Next »Leukemia Research
Volume 30, Issue 4 , Pages 407-413, April 2006

Wen-Lin Xu
- Department of Hematology, The Affiliated People's Hospital, Jiangsu University, 8 Dianli Road, Zhenjiang 212002, PR China
- Corresponding author. Tel.: +86 511 5246930; fax: +86 511 5234387.
Hui-Ling Shen
- Department of Hematology, The Affiliated People's Hospital, Jiangsu University, 8 Dianli Road, Zhenjiang 212002, PR China
Zhong-Fang Ao
- Department of Hematology, The First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, PR China
Bao-An Chen
- Department of Hematology, The Affiliated Zhong-Da Hospital, Southeast University, Nanjing 210009, PR China
Wei Xia
- Department of Hematology, The First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, PR China
Feng Gao
- Department of Hematology, The Affiliated Zhong-Da Hospital, Southeast University, Nanjing 210009, PR China
Yong-Ning Zhang
- Department of Hematology, The Affiliated People's Hospital, Jiangsu University, 8 Dianli Road, Zhenjiang 212002, PR China